Skip to content

Clinical outcome and implant survival after knee TEP change with anteroposterior instability

Clinical outcome and implant survival after knee TEP change with anteroposterior instability

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021479
Enrollment
100
Registered
2020-07-02
Start date
2023-02-17
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M17.9 M23.52

Interventions

Group 1: Patients who underwent surgery after the first knee endoprosthesis implantation were interviewed to investigate implant survival and the revision rate after the replacement operation.

Sponsors

Medizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Male or female patients aged = 18 at the time of enrollment - Knee TEP change performed due to anteroposterior instability of the knee joint

Exclusion criteria

Exclusion criteria: - Another revision of the knee TEP with replacement of individual or all components

Design outcomes

Primary

MeasureTime frame
The primary goal of this study is to examine implant survival and the revision rate of knee TEP replacement surgery due to anteroposterior instability of the knee joint. The different types of implants should be analyzed separately.

Secondary

MeasureTime frame
As a secondary goal, patient satisfaction and the subjective function of the joint should be examined in a patient survey using questionnaires. On the other hand, the radiological recordings that have already been made are to be analyzed pre- and postoperatively as well as progressive recordings with regard to common radiological criteria of knee arthroplasty (KSRESS, joint and implant position pre- and postoperative with common axis angles).

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift, Leitung Klinisches Studienmanagement

yvonne.noll@diakovere.de0511-5354-649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026